Due to the cytotoxic and cytostatic effects of somatostatin, the expression of SSTRs has been found to inversely correlate with MYCN amplification and to positively correlate with survival of patients with differentiated neuroblastomas [39–41]. This evidence concerns the gene MYCN and neuroblastoma.